Mainz BioMed N.V. | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
Mainz BioMed N.V.

BRIEF

published on 12/02/2025 at 14:06, 2 days 15 hours ago

DoctorBox Integrates ColoAlert® for Enhanced Home Cancer Screening

Mainz Biomed Colorectal Cancer ColoAlert® DoctorBox Home Screening
PRESS RELEASE

published on 12/02/2025 at 14:01, 2 days 16 hours ago

DoctorBox Adds Mainz Biomed’s ColoAlert® to Its Portfolio
Mainz Biomed's ColoAlert added to DoctorBox's digital health portfolio, advancing preventive medicine with innovative DNA-based colorectal cancer screening at home

ColoAlert Mainz Biomed Colorectal Cancer Screening DoctorBox DNA-based
BRIEF

published on 11/18/2025 at 14:06, 16 days 15 hours ago

Mainz Biomed Partners with OncoVanguard8 for ColoAlert Expansion in South America

South America ColoAlert Colorectal Cancer Diagnostic Testing OncoVanguard8
PRESS RELEASE

published on 11/18/2025 at 14:01, 16 days 16 hours ago

Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America
Mainz Biomed and OncoVanguard8 partner to introduce ColoAlert DNA-based colorectal cancer screening test to South America, starting with Peru, in a strategic move to enhance early detection and public health outcomes

South America ColoAlert Mainz Biomed DNA-based Test OncoVanguard8
BRIEF

published on 11/12/2025 at 14:06, 22 days 15 hours ago

Mainz Biomed Presents Cancer Detection Innovations at MEDICA 2025

Healthcare Innovation Mainz Biomed ColoAlert® Cancer Detection MEDICA 2025
PRESS RELEASE

published on 11/12/2025 at 14:01, 22 days 16 hours ago

Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025
Mainz Biomed to showcase cancer detection solutions at MEDICA 2025, a leading healthcare trade show in Düsseldorf. Event offers platform for innovation and business development

Innovation Mainz Biomed Cancer Detection MEDICA 2025 Healthcare Trade Show
BRIEF

published on 11/10/2025 at 14:06, 24 days 15 hours ago

Mainz Biomed to Participate in GARPS 2025 Conference

ColoAlert Mainz Biomed Cancer Detection GARPS 2025 Gastroenterology Conference
PRESS RELEASE

published on 11/10/2025 at 14:01, 24 days 16 hours ago

Mainz Biomed to Attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS)
Mainz Biomed N.V. to attend the 38th GARPS Annual Meeting in Germany to showcase its cancer detection solutions and strengthen partnerships with key opinion leaders in gastroenterology

ColoAlert Mainz Biomed Cancer Detection Gastroenterology 38th GARPS Annual Meeting
BRIEF

published on 10/15/2025 at 15:06, 1 month 20 days ago

Mainz Biomed to Join 2025 Maxim Growth Summit in NYC

Investors One-on-one Meetings Mainz Biomed Cancer Detection Maxim Growth Summit
PRESS RELEASE

published on 10/15/2025 at 15:01, 1 month 20 days ago

Mainz Biomed to Attend 2025 Maxim Growth Summit
Mainz Biomed N.V. to attend 2025 Maxim Growth Summit, featuring industry leaders and discussions on various sectors. Company specializes in cancer early detection

Biotechnology Mainz Biomed Cancer Detection Industry Leaders 2025 Maxim Growth Summit

Accesswire

Published on 12/05/2025 at 02:35, 3 hours 29 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 3 hours 34 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 5 hours 4 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 59 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 4 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 2 hours 33 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 13 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 38 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 49 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 53 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 12 hours 4 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 19 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 19 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 3 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE